Inhibition of miR-21 significantly reduced the proliferation of CCR6+ Tregs in vitro, altered the enrichment of CCR6+ Tregs in the tumor mass and exerted an effective antitumor effect on CD8+ T lymphocytes [21]. The gene discussed is CCR6; the disease is neoplasm.